Catherine Wood's TWST Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 7.56 M shares of Twist Bioscience Corporation (TWST) worth $239.79 M, representing 1.59% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in TWST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2020, adding 2.72 M shares. Largest reduction occurred in Q3 2021, reducing 1.11 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Twist Bioscience Corporation (TWST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Twist Bioscience Corporation (TWST) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +832,687 | Add 12.38% | 7.56 M | $31.72 |
| Q3 2025 | +326,367 | Add 5.10% | 6.73 M | $28.14 |
| Q2 2025 | +158,846 | Add 2.54% | 6.4 M | $36.79 |
| Q1 2025 | +645,730 | Add 11.54% | 6.24 M | $39.26 |
| Q4 2024 | +237,772 | Add 4.44% | 5.6 M | $46.47 |
| Q3 2024 | -771,282 | Reduce 12.58% | 5.36 M | $45.18 |
| Q2 2024 | -814,600 | Reduce 11.73% | 6.13 M | $49.28 |
| Q1 2024 | -269,282 | Reduce 3.73% | 6.94 M | $34.31 |
| Q4 2023 | +427,274 | Add 6.30% | 7.21 M | $36.86 |
| Q3 2023 | -173,257 | Reduce 2.49% | 6.79 M | $20.26 |
| Q2 2023 | -219,872 | Reduce 3.06% | 6.96 M | $20.46 |
| Q1 2023 | +478,257 | Add 7.14% | 7.18 M | $15.08 |
| Q4 2022 | +23,947 | Add 0.36% | 6.7 M | $23.81 |
| Q3 2022 | +409,187 | Add 6.53% | 6.68 M | $35.24 |
| Q2 2022 | +1 M | Add 19.06% | 6.27 M | $34.04 |
| Q1 2022 | +1.5 M | Add 39.74% | 5.26 M | $49.38 |
| Q4 2021 | -179,206 | Reduce 4.54% | 3.77 M | $77.39 |
| Q3 2021 | -1.11 M | Reduce 21.93% | 3.95 M | $106.97 |
| Q2 2021 | -990,656 | Reduce 16.39% | 5.05 M | $133.25 |
| Q1 2021 | +168,549 | Add 2.87% | 6.05 M | $123.86 |
| Q4 2020 | +2.72 M | Add 85.95% | 5.88 M | $141.29 |
| Q3 2020 | +1.52 M | Add 92.30% | 3.16 M | $75.97 |
| Q2 2020 | +999,397 | Add 155.16% | 1.64 M | $45.30 |
| Q1 2020 | +245,480 | Add 61.58% | 644,093 | $30.58 |
| Q4 2019 | +152,986 | Add 62.28% | 398,613 | $21.00 |
| Q3 2019 | +31,834 | Add 14.89% | 245,627 | $23.88 |
| Q2 2019 | +213,793 | New Buy | 213,793 | $29.01 |
Catherine Wood's Twist Bioscience Corporation Investment FAQs
Catherine Wood first purchased Twist Bioscience Corporation (TWST) in Q2 2019, acquiring 213,793 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Twist Bioscience Corporation (TWST) for 27 quarters since Q2 2019.
Catherine Wood's largest addition to Twist Bioscience Corporation (TWST) was in Q4 2020, adding 5,876,971 shares worth $830.36 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 7,559,495 shares of Twist Bioscience Corporation (TWST), valued at approximately $239.79 M.
As of the Q4 2025 filing, Twist Bioscience Corporation (TWST) represents approximately 1.59% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Twist Bioscience Corporation (TWST) was 7,559,495 shares, as reported at the end of Q4 2025.